ABVC BioPharma rises after CEO appointment

ABVC Biopharma

26/06/2023 16:39

** Shares of drug developer ABVC BioPharma Inc  ABVC.O  rise
7.7% to $0.57
    ** Co announces appointment of Dr. Uttam Yashwant Patil  as
the new chief executive officer, effective June 23
    ** Patil has previously been chief operating officer & chief
scientific officer of BioKey Inc, a facility owned by ABVC
    ** Stock down ~7% YTD

 (Reporting by Sriparna Roy in Bengaluru)
 ((Sriparna.Roy@thomsonreuters.com;))